OR Royalties Target of Unusually Large Options Trading (NYSE:OR)

OR Royalties Inc. (NYSE:OR) saw some unusual options trading activity on Tuesday. Traders acquired 7,046 call options on the stock. This represents an increase of 908% compared to the average volume of 699 call options.

Wall Street Analyst Weigh In

Several analysts have recently commented on the stock. Raymond James Financial raised shares of OR Royalties from a “market perform” rating to an “outperform” rating and set a $41.00 price target on the stock in a research report on Thursday, November 6th. Wall Street Zen cut OR Royalties from a “strong-buy” rating to a “buy” rating in a research note on Sunday. Zacks Research lowered OR Royalties from a “strong-buy” rating to a “hold” rating in a research note on Friday, December 19th. Jefferies Financial Group reissued a “hold” rating and set a $38.00 price objective on shares of OR Royalties in a research report on Sunday, December 7th. Finally, Weiss Ratings reaffirmed a “buy (b)” rating on shares of OR Royalties in a research report on Monday, December 29th. One analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $35.75.

Institutional Investors Weigh In On OR Royalties

A number of hedge funds have recently bought and sold shares of OR. Euro Pacific Asset Management LLC grew its position in shares of OR Royalties by 0.7% during the fourth quarter. Euro Pacific Asset Management LLC now owns 1,028,079 shares of the basic materials company’s stock worth $36,088,000 after buying an additional 7,579 shares in the last quarter. New England Professional Planning Group Inc. purchased a new position in OR Royalties in the fourth quarter worth approximately $229,000. CWA Asset Management Group LLC grew its holdings in OR Royalties by 7.1% during the 4th quarter. CWA Asset Management Group LLC now owns 408,918 shares of the basic materials company’s stock worth $14,472,000 after acquiring an additional 27,171 shares in the last quarter. Swiss Life Asset Management Ltd acquired a new position in OR Royalties during the 3rd quarter worth approximately $355,000. Finally, Polar Asset Management Partners Inc. increased its position in shares of OR Royalties by 261.5% in the 3rd quarter. Polar Asset Management Partners Inc. now owns 141,000 shares of the basic materials company’s stock valued at $5,652,000 after purchasing an additional 102,000 shares during the last quarter. Institutional investors and hedge funds own 68.52% of the company’s stock.

OR Royalties Stock Down 0.5%

NYSE:OR traded down $0.22 on Thursday, reaching $40.56. 298,634 shares of the company’s stock were exchanged, compared to its average volume of 1,397,406. The firm has a market capitalization of $7.59 billion, a price-to-earnings ratio of 51.37 and a beta of 0.78. OR Royalties has a 52-week low of $17.55 and a 52-week high of $42.25. The business has a fifty day moving average of $35.12 and a 200-day moving average of $33.38.

OR Royalties (NYSE:OR) last announced its quarterly earnings data on Wednesday, November 5th. The basic materials company reported $0.22 earnings per share for the quarter, beating analysts’ consensus estimates of $0.19 by $0.03. The firm had revenue of $71.63 million during the quarter, compared to analysts’ expectations of $53.85 million. OR Royalties had a net margin of 60.72% and a return on equity of 10.67%. As a group, equities analysts anticipate that OR Royalties will post 0.62 earnings per share for the current year.

OR Royalties Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Wednesday, December 31st will be issued a $0.055 dividend. The ex-dividend date is Wednesday, December 31st. This represents a $0.22 dividend on an annualized basis and a yield of 0.5%. OR Royalties’s dividend payout ratio (DPR) is 27.85%.

About OR Royalties

OR Royalties PLC (NYSE: OR) is a closed-ended investment company that specializes in acquiring and managing royalty interests in life science and pharmaceutical products. The company provides capital to biotechnology, specialty pharmaceutical and medical device companies in exchange for a share of future sales revenues. By focusing on royalties secured against marketed products, OR Royalties aims to deliver income and growth potential while minimizing the development and commercialization risks typically associated with direct equity stakes.

The company’s core activities include sourcing royalty transactions, structuring bespoke financing solutions and actively monitoring a diversified portfolio of assets.